ANDREW GUGGENHIME
CIK 1230724 · PRESIDENT AND CFO · last filed 2026-07-06
ANDREW GUGGENHIME is a PRESIDENT AND CFO who has filed 104 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for PCVX, was dated Aug 3, 2026. Across all open-market trades the lifetime net is −$20.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$10.53M
6
104
-$20.14M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCVX | PRESIDENT AND CFO | 168,332 | $58.89 | $9.91M | -$18.16M | 48 | 2026-07-06 |
| CRBU | Director | — | $1.64 | — | $0 | 5 | 2026-02-20 |
| Metacrine, Inc. (MTCR) Delisted | Director | — | $0.49 | — | $0 | 2 | 2022-09-06 |
| DERM | CFO | 42,159 | $6.53 | $275.3K | -$1.98M | 15 | 2019-08-19 |
| FACT | SVP & CFO | 32,090 | $10.67 | $342.4K | $0 | 5 | 2010-04-21 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | SVP & Chief Financial Officer | 13,255 | — | — | $0 | 5 | 2008-12-19 |
Recent Filings
104 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-03 | PCVX | Notice (144) | −10,000 | -$539.9K | EDGAR |
| 2026-07-06 | PCVX | Notice (144) | −10,000 | -$577.6K | EDGAR |
| 2026-07-06 | PCVX | Mixed | — | -$519.3K | EDGAR |
| 2026-06-18 | PCVX | Notice (144) | −10,000 | -$530.0K | EDGAR |
| 2026-06-18 | PCVX | Mixed | — | -$476.5K | EDGAR |
| 2026-03-11 | PCVX | Tax (F) | −1,021 | -$60.6K | EDGAR |
| 2026-03-02 | PCVX | Mixed | +42,957 | -$118.2K | EDGAR |
| 2026-02-20 | CRBU | Grant (A) | — | $0 | EDGAR |
| 2026-01-16 | PCVX | Gift (G) | — | $0 | EDGAR |
| 2025-09-10 | PCVX | Tax (F) | −2,890 | -$93.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.